Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Correction: Macroscale abundance patterns of hydromedusae in the temperate Southwestern Atlantic (27°-56° S).

Dutto MS, Chazarreta CJ, Rodriguez CS, Schiariti A, Briz LMD, Genzano GN.

PLoS One. 2020 Feb 20;15(2):e0229678. doi: 10.1371/journal.pone.0229678. eCollection 2020.

2.

Enhanced Heavy Metal Removal from Acid Mine Drainage Wastewater Using Double-Oxidized Multiwalled Carbon Nanotubes.

Rodríguez C, Leiva E.

Molecules. 2019 Dec 27;25(1). pii: E111. doi: 10.3390/molecules25010111.

3.

Classroom-comfort-data: A method to collect comprehensive information on thermal comfort in school classrooms.

Rodriguez CM, Coronado MC, Medina JM.

MethodsX. 2019 Nov 7;6:2698-2719. doi: 10.1016/j.mex.2019.11.004. eCollection 2019.

4.

Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.

Huerta-Ramos E, Labad J, Cobo J, Núñez C, Creus M, García-Parés G, Cuadras D, Franco J, Miquel E, Reyes JC, Marcó-García S; RALOPSYCAT Group, Usall J.

Eur Arch Psychiatry Clin Neurosci. 2019 Nov 14. doi: 10.1007/s00406-019-01079-w. [Epub ahead of print]

PMID:
31728631
5.

Macroscale abundance patterns of hydromedusae in the temperate Southwestern Atlantic (27°-56° S).

Dutto MS, Chazarreta CJ, Rodriguez CS, Schiariti A, Diaz Briz LM, Genzano GN.

PLoS One. 2019 Jun 19;14(6):e0217628. doi: 10.1371/journal.pone.0217628. eCollection 2019. Erratum in: PLoS One. 2020 Feb 20;15(2):e0229678.

6.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.

PMID:
31189511
7.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9.

PMID:
31189509
8.

Older Blood Is Associated With Increased Mortality and Adverse Events in Massively Transfused Trauma Patients: Secondary Analysis of the PROPPR Trial.

Jones AR, Patel RP, Marques MB, Donnelly JP, Griffin RL, Pittet JF, Kerby JD, Stephens SW, DeSantis SM, Hess JR, Wang HE; PROPPR Study Group.

Ann Emerg Med. 2019 Jun;73(6):650-661. doi: 10.1016/j.annemergmed.2018.09.033. Epub 2018 Nov 15.

PMID:
30447946
9.

Elevated Syndecan-1 after Trauma and Risk of Sepsis: A Secondary Analysis of Patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial.

Wei S, Gonzalez Rodriguez E, Chang R, Holcomb JB, Kao LS, Wade CE; PROPPR Study Group.

J Am Coll Surg. 2018 Dec;227(6):587-595. doi: 10.1016/j.jamcollsurg.2018.09.003. Epub 2018 Sep 21.

10.

Arsenic removal mediated by acidic pH neutralization and iron precipitation in microbial fuel cells.

Leiva E, Leiva-Aravena E, Rodríguez C, Serrano J, Vargas I.

Sci Total Environ. 2018 Dec 15;645:471-481. doi: 10.1016/j.scitotenv.2018.06.378. Epub 2018 Jul 18. No abstract available.

PMID:
30029122
11.

Onset of Coagulation Function Recovery Is Delayed in Severely Injured Trauma Patients with Venous Thromboembolism.

McCully BH, Connelly CR, Fair KA, Holcomb JB, Fox EE, Wade CE, Bulger EM, Schreiber MA; PROPPR Study Group.

J Am Coll Surg. 2017 Jul;225(1):42-51. doi: 10.1016/j.jamcollsurg.2017.03.001. Epub 2017 Mar 16.

12.

Census of Cnidaria (Medusozoa) and Ctenophora from South American marine waters.

Oliveira OM, Miranda TP, Araujo EM, Ayón P, Cedeño-Posso CM, Cepeda-Mercado AA, Córdova P, Cunha AF, Genzano GN, Haddad MA, Mianzan HW, Migotto AE, Miranda LS, Morandini AC, Nagata RM, Nascimento KB, Júnior MN, Palma S, Quiñones J, Rodriguez CS, Scarabino F, Schiariti A, Stampar SN, Tronolone VB, Marques AC.

Zootaxa. 2016 Nov 17;4194(1):zootaxa.4194.1.1. doi: 10.11646/zootaxa.4194.1.1.

PMID:
27988700
13.

Damage-control resuscitation and emergency laparotomy: Findings from the PROPPR study.

Undurraga Perl VJ, Leroux B, Cook MR, Watson J, Fair K, Martin DT, Kerby JD, Williams C, Inaba K, Wade CE, Cotton BA, Del Junco DJ, Fox EE, Scalea TM, Tilley BC, Holcomb JB, Schreiber MA; PROPPR Study Group.

J Trauma Acute Care Surg. 2016 Apr;80(4):568-74; discussion 574-5. doi: 10.1097/TA.0000000000000960.

14.

Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.

Usall J, Huerta-Ramos E, Labad J, Cobo J, Núñez C, Creus M, Parés GG, Cuadras D, Franco J, Miquel E, Reyes JC, Roca M; RALOPSYCAT Group.

Schizophr Bull. 2016 Mar;42(2):309-17. doi: 10.1093/schbul/sbv149. Epub 2015 Nov 20.

15.

Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014.

Jiménez-Jorge S, Pozo F, Larrauri A; cycEVA Study Team.

Vaccine. 2015 Jun 26;33(29):3276-80. doi: 10.1016/j.vaccine.2015.03.051. Epub 2015 Apr 11.

PMID:
25869892
16.

Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial.

Novak DJ, Bai Y, Cooke RK, Marques MB, Fontaine MJ, Gottschall JL, Carey PM, Scanlan RM, Fiebig EW, Shulman IA, Nelson JM, Flax S, Duncan V, Daniel-Johnson JA, Callum JL, Holcomb JB, Fox EE, Baraniuk S, Tilley BC, Schreiber MA, Inaba K, Rizoli S, Podbielski JM, Cotton BA, Hess JR; PROPPR Study Group.

Transfusion. 2015 Jun;55(6):1331-9. doi: 10.1111/trf.13098. Epub 2015 Mar 30.

17.

Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.

Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, Cohen MJ, Cotton BA, Fabian TC, Inaba K, Kerby JD, Muskat P, O'Keeffe T, Rizoli S, Robinson BR, Scalea TM, Schreiber MA, Stein DM, Weinberg JA, Callum JL, Hess JR, Matijevic N, Miller CN, Pittet JF, Hoyt DB, Pearson GD, Leroux B, van Belle G; PROPPR Study Group.

JAMA. 2015 Feb 3;313(5):471-82. doi: 10.1001/jama.2015.12.

18.

Anti-smoking legislation and its effects on urinary cotinine and cadmium levels.

Sánchez-Rodríguez JE, Bartolomé M, Cañas AI, Huetos O, Navarro C, Rodríguez AC, Arribas M, Esteban M, López A, Castaño A.

Environ Res. 2015 Jan;136:227-33. doi: 10.1016/j.envres.2014.09.033. Epub 2014 Nov 20.

19.

Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation.

Baraniuk S, Tilley BC, del Junco DJ, Fox EE, van Belle G, Wade CE, Podbielski JM, Beeler AM, Hess JR, Bulger EM, Schreiber MA, Inaba K, Fabian TC, Kerby JD, Cohen MJ, Miller CN, Rizoli S, Scalea TM, O'Keeffe T, Brasel KJ, Cotton BA, Muskat P, Holcomb JB; PROPPR Study Group.

Injury. 2014 Sep;45(9):1287-95. doi: 10.1016/j.injury.2014.06.001. Epub 2014 Jun 10.

20.

Toxoplasmosis of the spinal cord in an immunocompromised patient: case report and review of the literature.

Rodríguez C, Martínez E, Bolívar G, Sánchez S, Carrascal E.

Colomb Med (Cali). 2013 Dec 31;44(4):232-5. eCollection 2013 Oct.

Supplemental Content

Loading ...
Support Center